Researchers from China analyzed UK Biobank data from 124,445 patients for any association to cardiovascular disease, heart failure, stroke and death from benzodiazepine and non-benzodiazepine hypnotic agents used to treat insomnia.
The UK Biobank is a biomedical database containing health information from 500,000 participants for research use, with data being collected since 2006.
Non-benzodiazepine hypnotic agents, also called z-meds, are eszopiclone, zolpidem and zaleplon. Benzodiazepine hypnotic agents include lorazepam, alprazolam, diazepam and triazolam.
During a median follow-up period of 14.3 years, researchers found a significant association with benzodiazepine use and an increased risk of cardiovascular disease, mortality and heart failure. No similar association was found with z-med use, according to the study.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
